<bill session="117" type="h" number="7505" updated="2022-12-29T23:03:23Z">
  <state datetime="2022-04-14">REFERRED</state>
  <status>
    <introduced datetime="2022-04-14"/>
  </status>
  <introduced datetime="2022-04-14"/>
  <titles>
    <title type="display">To amend the Internal Revenue Code of 1986 to add a new medical research component to the credit for increasing research activities.</title>
    <title type="official" as="introduced">To amend the Internal Revenue Code of 1986 to add a new medical research component to the credit for increasing research activities.</title>
  </titles>
  <sponsor bioguide_id="B001260"/>
  <cosponsors>
    <cosponsor bioguide_id="K000376" joined="2022-04-14"/>
  </cosponsors>
  <actions>
    <action datetime="2022-04-14">
      <text>Introduced in House</text>
    </action>
    <action datetime="2022-04-14" state="REFERRED">
      <text>Referred to the House Committee on Ways and Means.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSWM" name="House Ways and Means" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Taxation"/>
  </subjects>
  <amendments/>
  <summary date="2022-04-20T16:50:53Z" status="Introduced in House">This bill expands the tax credit for increasing research activities to add a new credit amount equal to 14% of specified medical research expenditures. The bill defines specified medical research expenditures as amounts paid or incurred for research with respect to any qualified countermeasure (i.e., a drug, biological product, or device determined to be a priority in protecting against harm from a biological agent or adverse health condition).</summary>
</bill>
